<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" position="float">
 <label>Table 3</label>
 <caption>
  <p>Differentiating features of Zika, Dengue, and Chikungunya</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">Features</th>
    <th align="left" rowspan="1" colspan="1">Dengue</th>
    <th align="left" rowspan="1" colspan="1">Zika</th>
    <th align="left" rowspan="1" colspan="1">Chikungunya</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Incubation period</td>
    <td align="left" rowspan="1" colspan="1">3-14 days</td>
    <td align="left" rowspan="1" colspan="1">3-12 days</td>
    <td align="left" rowspan="1" colspan="1">1-12 days</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Etiology</td>
    <td align="left" rowspan="1" colspan="1">RNA virus belongs to the genus 
     <italic>Flavivirus</italic> of family 
     <italic>Flaviviridae</italic>. (4 different serological types exists - DENV 1, 2, 3 and 4) Mostly, Infection with one serotype Leads to lifelong immunity against the same type. However, occasionally, exposure of the individual to a second type of dengue virus Leads to a very severe form of illness (dengue shock syndrome and dengue hemorrhagic fever)
    </td>
    <td align="left" rowspan="1" colspan="1">RNA virus belongs to the genus 
     <italic>Flavivirus</italic>of family 
     <italic>Flaviviridae</italic>. Lifelong immunity after infection with one type has not been reported in Zika virus infections
    </td>
    <td align="left" rowspan="1" colspan="1">RNA virus of genus 
     <italic>Alphavirus</italic>of the family 
     <italic>Togaviridae</italic>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Fever (duration)</td>
    <td align="left" rowspan="1" colspan="1">Higher (≥40°)
     <break/>+++
     <break/>Lasts for 4-7 days
    </td>
    <td align="left" rowspan="1" colspan="1">Lower (≤38.5)
     <break/>++
     <break/>Lasts for 1-2 days
    </td>
    <td align="left" rowspan="1" colspan="1">High fever++Lasts for 2-3 days</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Rash (maculopapular exanthema)</td>
    <td align="left" rowspan="1" colspan="1">Moderately elevated
     <break/>+
    </td>
    <td align="left" rowspan="1" colspan="1">Elevated
     <break/>+++
    </td>
    <td align="left" rowspan="1" colspan="1">Moderately elevated
     <break/>++
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Headaches</td>
    <td align="left" rowspan="1" colspan="1">Frequent and high intensity +++</td>
    <td align="left" rowspan="1" colspan="1">Frequent and moderate intensity +</td>
    <td align="left" rowspan="1" colspan="1">Frequent and moderate intensity +</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Arthralgia</td>
    <td align="left" rowspan="1" colspan="1">Mild</td>
    <td align="left" rowspan="1" colspan="1">Mild/moderate</td>
    <td align="left" rowspan="1" colspan="1">Frequent and in multiple joints +++</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nausea and vomiting</td>
    <td align="left" rowspan="1" colspan="1">Seen</td>
    <td align="left" rowspan="1" colspan="1">Unusual</td>
    <td align="left" rowspan="1" colspan="1">Unusual</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Blood dyscrasias (shock and thrombocytopenia)</td>
    <td align="left" rowspan="1" colspan="1">+++</td>
    <td align="left" rowspan="1" colspan="1">+/_</td>
    <td align="left" rowspan="1" colspan="1">+/_</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Non-purulent conjunctivitis</td>
    <td align="left" rowspan="1" colspan="1">+</td>
    <td align="left" rowspan="1" colspan="1">+++</td>
    <td align="left" rowspan="1" colspan="1">++</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Peripheral edema</td>
    <td align="left" rowspan="1" colspan="1">_</td>
    <td align="left" rowspan="1" colspan="1">+</td>
    <td align="left" rowspan="1" colspan="1">_</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">lymphadenopathy</td>
    <td align="left" rowspan="1" colspan="1">++</td>
    <td align="left" rowspan="1" colspan="1">+</td>
    <td align="left" rowspan="1" colspan="1">++</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Neurological complications</td>
    <td align="left" rowspan="1" colspan="1">Encephalitis</td>
    <td align="left" rowspan="1" colspan="1">Guillain-Barré syndrome and encephalitis</td>
    <td align="left" rowspan="1" colspan="1">Guillain-Barré syndrome and encephalitis (especially in neonates)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Course of disease</td>
    <td align="left" rowspan="1" colspan="1">Mostly, dengue infection is benign and limited to fever during the acute phase followed by a Gradual return to normal. Occasionally, after exposure to secondary serological type of dengue, there are three distinct phases of disease: an acute febrile phase, a critical (plasma leak) phase where hematologic abnormalities, shock and death can occur, and a recovery phase</td>
    <td align="left" rowspan="1" colspan="1">Usually self-limiting (2-7 days)</td>
    <td align="left" rowspan="1" colspan="1">The illness is usually self-limiting and resolves with time. However, preexisting signs of chronic joint disease and other causes of chronic rheumatism predispose patients to chronicity of chikungunya infection</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Hospitalization</td>
    <td align="left" rowspan="1" colspan="1">Secondary dengue infection often requires hospitalization and 2.5% of infected individuals will develop a lethal illness</td>
    <td align="left" rowspan="1" colspan="1">Most cases are managed on an outpatient basis</td>
    <td align="left" rowspan="1" colspan="1">Patients with severe chikungunya fever requiring hospitalization tend to be older and have comorbidities such as cardiovascular, neurologic, and respiratory disorders or diabetes</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Role of NSAIDS</td>
    <td align="left" rowspan="1" colspan="1">NSAIDS can increase risk of bleeding</td>
    <td align="left" rowspan="1" colspan="1">Acceptable to use in Zika virus infection as long as dengue has been excluded</td>
    <td align="left" rowspan="1" colspan="1">Taking nonsteroidal anti-inflammatory drugs may reducethe symptoms of fever and pain</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Neutropenia</td>
    <td align="left" rowspan="1" colspan="1">++</td>
    <td align="left" rowspan="1" colspan="1">Not demonstrable</td>
    <td align="left" rowspan="1" colspan="1">+</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Lymphopenia</td>
    <td align="left" rowspan="1" colspan="1">++</td>
    <td align="left" rowspan="1" colspan="1">Not demonstrable</td>
    <td align="left" rowspan="1" colspan="1">+++</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>NSAIDS=Nonsteroidal anti-inflammatory drugs. +: Mild, ++: Moderate, +++: Severe, +/-: May or may not be present</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
